Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Ferris

Showing results (441-450 of 460) with videos related to

Pageof 46
Sort By:
Antimicrobial Agents and Chemotherapy|September 29, 2005
Antiviral activity of GW678248, a novel benzophenone nonnucleoside reverse transcriptase inhibitorRobert G Ferris, Richard J Hazen, Grace B Roberts, et al.
The New England Journal of Medicine|May 15, 2007
Quadrivalent vaccine against human papillomavirus to prevent anogenital diseasesSuzanne M Garland, Mauricio Hernandez-Avila, Cosette M Wheeler, et al.
CA: a Cancer Journal for Clinicians|January 24, 2007
American Cancer Society Guideline for human papillomavirus (HPV) vaccine use to prevent cervical cancer and its precursorsDebbie Saslow, Philip E Castle, J Thomas Cox, et al.
Lancet (London, England)|May 22, 2007
Efficacy of a quadrivalent prophylactic human papillomavirus (types 6, 11, 16, and 18) L1 virus-like-particle vaccine against high-grade vulval and vaginal lesions: a combined analysis of three randomised clinical trialsElmar A Joura, Sepp Leodolter, Mauricio Hernandez-Avila, et al.
Journal of Medicinal Chemistry|February 20, 2004
Novel benzophenones as non-nucleoside reverse transcriptase inhibitors of HIV-1Joseph H Chan, George A Freeman, Jeffrey H Tidwell, et al.
Antimicrobial Agents and Chemotherapy|December 28, 2007
The naphthyridinone GSK364735 is a novel, potent human immunodeficiency virus type 1 integrase inhibitor and antiretroviralEdward P Garvey, Brian A Johns, Margaret J Gartland, et al.
International Journal of Cancer|October 16, 2010
Adenocarcinoma in situ and associated human papillomavirus type distribution observed in two clinical trials of a quadrivalent human papillomavirus vaccineKevin A Ault, Elmar A Joura, Susanne K Kjaer, et al.
Neuroinformatics|September 23, 2024
Mesoscale Brain Mapping: Bridging Scales and Modalities in Neuroimaging - A Symposium ReviewJoshua K Marchant, Natalie G Ferris, Diana Grass, et al.
Papillomavirus Research (Amsterdam, Netherlands)|October 28, 2017
Human papillomavirus detection in cervical neoplasia attributed to 12 high-risk human papillomavirus genotypes by regionXavier Castellsagué, Kevin A Ault, F Xavier Bosch, et al.
Journal of Medicinal Chemistry|November 13, 2004
Design of non-nucleoside inhibitors of HIV-1 reverse transcriptase with improved drug resistance properties. 2George A Freeman, C Webster Andrews Iii, Andrew L Hopkins, et al.
Pageof 46

Showing results (441-450 of 460) with videos related to

Sort By:
Pageof 46
Antimicrobial Agents and Chemotherapy|September 29, 2005
Antiviral activity of GW678248, a novel benzophenone nonnucleoside reverse transcriptase inhibitorRobert G Ferris, Richard J Hazen, Grace B Roberts, et al.
The New England Journal of Medicine|May 15, 2007
Quadrivalent vaccine against human papillomavirus to prevent anogenital diseasesSuzanne M Garland, Mauricio Hernandez-Avila, Cosette M Wheeler, et al.
CA: a Cancer Journal for Clinicians|January 24, 2007
American Cancer Society Guideline for human papillomavirus (HPV) vaccine use to prevent cervical cancer and its precursorsDebbie Saslow, Philip E Castle, J Thomas Cox, et al.
Lancet (London, England)|May 22, 2007
Efficacy of a quadrivalent prophylactic human papillomavirus (types 6, 11, 16, and 18) L1 virus-like-particle vaccine against high-grade vulval and vaginal lesions: a combined analysis of three randomised clinical trialsElmar A Joura, Sepp Leodolter, Mauricio Hernandez-Avila, et al.
Journal of Medicinal Chemistry|February 20, 2004
Novel benzophenones as non-nucleoside reverse transcriptase inhibitors of HIV-1Joseph H Chan, George A Freeman, Jeffrey H Tidwell, et al.
Antimicrobial Agents and Chemotherapy|December 28, 2007
The naphthyridinone GSK364735 is a novel, potent human immunodeficiency virus type 1 integrase inhibitor and antiretroviralEdward P Garvey, Brian A Johns, Margaret J Gartland, et al.
International Journal of Cancer|October 16, 2010
Adenocarcinoma in situ and associated human papillomavirus type distribution observed in two clinical trials of a quadrivalent human papillomavirus vaccineKevin A Ault, Elmar A Joura, Susanne K Kjaer, et al.
Neuroinformatics|September 23, 2024
Mesoscale Brain Mapping: Bridging Scales and Modalities in Neuroimaging - A Symposium ReviewJoshua K Marchant, Natalie G Ferris, Diana Grass, et al.
Papillomavirus Research (Amsterdam, Netherlands)|October 28, 2017
Human papillomavirus detection in cervical neoplasia attributed to 12 high-risk human papillomavirus genotypes by regionXavier Castellsagué, Kevin A Ault, F Xavier Bosch, et al.
Journal of Medicinal Chemistry|November 13, 2004
Design of non-nucleoside inhibitors of HIV-1 reverse transcriptase with improved drug resistance properties. 2George A Freeman, C Webster Andrews Iii, Andrew L Hopkins, et al.
Pageof 46